A Review of the Current State of Off‐Label Therapies for Pediatric Inflammatory Bowel Disease

A Review of the Current State of Off‐Label Therapies for Pediatric Inflammatory Bowel Disease

ABSTRACT Off‐label use of biologic therapies in patients with pediatric inflammatory bowel disease (IBD) has seen an increase in utilization. In this paper, we review the current state of off‐label therapies in the pediatric IBD population. Real‐world use of ustekinumab (UST), vedolizumab (VDZ), upa...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Yassin EL‐Najjar, Mary‐Joe Touma, Shuai Tan, Xiaoqin Zhou, Qi Liu
Formaat: Artikel
Taal:Engels
Gepubliceerd in: Wiley 2025-06-01
Reeks:Pediatric Discovery
Onderwerpen:
biologic therapy
Crohn’s disease (CD)
pediatric inflammatory bowel disease 
small molecule
ulcerative colitis (UC)
Online toegang:https://doi.org/10.1002/pdi3.70011
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items